Eva Hellström‐Lindberg

26.9k citations
188 papers · 10.7k · 3 hit papers · h-index 41

Impact in

  • Hematology top 0.02%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders

Papers in

    • Acute Myeloid Leukemia Research 136
    • Hematopoietic Stem Cell Transplantation 21
    • Multiple Myeloma Research and Treatments 15
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 40
    • Chronic Lymphocytic Leukemia Research 30
    • Hemoglobinopathies and Related Disorders 20

Eva Hellström‐Lindberg

178 papers receiving 10.6k citations

Eva Hellström‐Lindberg's Hit Papers

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes 2009 · 3.0k citations
3.0k0+5+11Years since publication10002.0k3.0k

Peers

Eva Hellström‐Lindberg
Comparison fields: 5 of 131
  • Hematology 7.9k
  • Genetics 3.3k
  • Emergency Medicine 491
  • Molecular Biology 3.5k
  • Cancer Research 619
Replace Aristoteles Giagounidis with:
Aristoteles Giagounidis Germany
Uwe Platzbecker Germany
Azra Raza United States
Peter L. Greenberg United States
Rami S. Komrokji United States
Jürgen Thiele Germany
Claudia Schoch Germany
Tapan M. Kadia United States
David Grimwade United Kingdom
Claude Preudhomme France
Eva Hellström‐Lindberg relative to Aristoteles Giagounidis Germany Aristoteles Giagounidis's profile →
Citations per field
00.5×1.5×
Aristoteles Giagounidis · 1×
Citations per year

Countries citing papers authored by Eva Hellström‐Lindberg

Since Specialization
Citations

This map shows the geographic impact of Eva Hellström‐Lindberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellström‐Lindberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellström‐Lindberg more than expected).

Fields of papers citing papers by Eva Hellström‐Lindberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hellström‐Lindberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellström‐Lindberg. The network helps show where Eva Hellström‐Lindberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Hellström‐Lindberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Hellström‐Lindberg Line = papers co-authored together Eva Hellström‐Lindberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
Hit paper breakdown →
20093014
2
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Hit paper breakdown →
20091774
3
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Hit paper breakdown →
2009702
4 2011334
5 2003319
6 1995255
7 2008184
8 2000177
9 2009127
10 2017122
11 2007111
12 2013102
13 2010101
14 201498
15 199994
16 201093
17 201192
18 201888
19 201088
20 201087

About Eva Hellström‐Lindberg

Eva Hellström‐Lindberg is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Oncology, having authored 188 papers that have together received 10.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (136 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (30 papers), Hematopoietic Stem Cell Transplantation (21 papers), Hemoglobinopathies and Related Disorders (20 papers), Multiple Myeloma Research and Treatments (15 papers), Histone Deacetylase Inhibitors Research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). The work is most often cited by research in Hematology (7.9k citations), Genetics (3.3k citations), Emergency Medicine (491 citations), Molecular Biology (3.5k citations) and Cancer Research (619 citations). Eva Hellström‐Lindberg has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Anna Porwit, Daniel A. Arber, James W. Vardiman, Ayalew Tefferi, Michelle M. Le Beau, Jüergen Thiele, Nancy L. Harris, Michael J. Borowitz, Richard D. Brunning and Clara D. Bloomfield. Their work appears in journals such as Blood, Leukemia Research, British Journal of Haematology, Leukemia and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact